Healthcare Companies By Ps Ratio

LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Price To Sales
Return On Equity
Return On Asset
Profit Margin
Operating Margin
Current Valuation
Shares Outstanding
Shares Owned By Insiders
Shares Owned By Institutions
Number Of Shares Shorted
Price To Earning
Price To Book
Price To Sales
Revenue
Gross Profit
EBITDA
Net Income
Cash And Equivalents
Cash Per Share
Total Debt
Debt To Equity
Current Ratio
Book Value Per Share
Cash Flow From Operations
Short Ratio
Earnings Per Share
Price To Earnings To Growth
Target Price
Number Of Employees
Beta
Market Capitalization
Total Asset
Retained Earnings
Working Capital
Current Asset
Current Liabilities
Price To SalesEfficiencyMarket RiskExp Return
1VRDN Viridian Therapeutics
4.75 K
(0.09)
 4.41 
(0.40)
2NWBO Northwest Biotherapeutics
858.96
 0.02 
 4.06 
 0.08 
3GELS Gelteq Limited Ordinary
156.87
 0.05 
 19.88 
 1.07 
4BSGM BioSig Technologies, Common
90.04
 0.17 
 13.17 
 2.21 
5SILO Silo Pharma
77.69
 0.13 
 9.09 
 1.19 
6EUDA EUDA Health Holdings
36.07
(0.01)
 6.20 
(0.04)
7LLY Eli Lilly and
15.97
(0.15)
 2.15 
(0.33)
8NTRA Natera Inc
14.52
 0.14 
 3.54 
 0.50 
9BSX Boston Scientific Corp
9.14
 0.16 
 1.18 
 0.19 
10IDXX IDEXX Laboratories
9.13
(0.06)
 1.93 
(0.11)
11WAT Waters
8.29
 0.10 
 3.02 
 0.29 
12TLX Telix Pharmaceuticals Limited
8.09
 0.10 
 2.84 
 0.27 
13MGRX Mangoceuticals, Common Stock
7.49
 0.05 
 3.16 
 0.16 
14VCYT Veracyte
7.39
 0.13 
 2.77 
 0.37 
15DHR Danaher
7.36
(0.15)
 1.33 
(0.20)
16WGS GeneDx Holdings Corp
7.14
 0.07 
 7.77 
 0.54 
17SYK Stryker
6.65
 0.06 
 1.26 
 0.08 
18A Agilent Technologies
6.59
 0.09 
 1.54 
 0.14 
19GH Guardant Health
6.54
 0.26 
 3.73 
 0.98 
20EW Edwards Lifesciences Corp
6.52
 0.00 
 1.49 
 0.00 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries. The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY